Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
比较氟达拉滨/美法仑(FM140)与氟达拉滨/美法仑/卡莫司汀(FBM110)方案治疗接受异基因造血干细胞移植的复发/难治性急性髓系白血病患者的疗效——一项代表欧洲骨髓移植协会急性白血病工作组开展的注册研究
期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-024-02499-6
Duque-Afonso, Jesús; Finke, Jürgen; Ngoya, Maud; Galimard, Jacques-Emmanuel; Schetelig, Johannes; Eder, Matthias; Rösler, Wolf; Bug, Gesine; Neubauer, Andreas; Edinger, Matthias; Wulf, Gerald G; Jindra, Pavel; Einsele, Hermann; Stelljes, Matthias; Selleslag, Dominik; Wagner-Drouet, Eva Maria; Bunjes, Donald; Spyridonidis, Alexandros; Brissot, Eolia; Nagler, Arnon; Ciceri, Fabio; Mohty, Mohamad